Home » View latest Human Drug Tenders from India

View latest Human Drug Tenders from India

TendersOnTime provides latest updates on Indian Human Drug Tenders from various state and central government tendering authorities. The information on Human Drug online tenders and turnkey projects from India is collected from various sources viz: e procurement tenders list, newspapers and tender bulletin etc.

Country: India

Inj. 20 % Human Albumin (The Drug Contains 20% Human Albumin I/V Infusion Formulation. Packed

TOT Ref No.: 99952006

Deadline: 22 Apr 2024

Country: India

Supply of Of Pvms no 011075, Injection Pegylated Recombinant Human Erythropoietin75Mcg / 0.3

TOT Ref No.: 99860954

Deadline: 23 Apr 2024

Country: India

Supply Of Drugs & Injections- D2

TOT Ref No.: 98464684

Deadline: 08 May 2024

Country: India

Human Neutral Insulin

TOT Ref No.: 99944170

Deadline: 22 Apr 2024

Country: India

Human Neutral Insulin

TOT Ref No.: 99944188

Deadline: 22 Apr 2024

Country: India

Inj Human Insulin Mixture of 30% Human Neutral Insulin 70% Human Isophane Insulin(Nph) /40 Iu

TOT Ref No.: 100124740

Deadline: 29 Apr 2024

Country: India

Human Papilloma Virus Vaccine Quadrivale [Human Papilloma Virus Vaccine Quadrivalent (Gardasil)

TOT Ref No.: 99949138

Deadline: 19 Apr 2024

Country: India

Human Neutral Insulin 40Iu Per Ml 10Ml [Human Neutral Insulin 40Iu Per Ml 10Ml Vial]

TOT Ref No.: 100022992

Deadline: 23 Apr 2024

Country: India

Supply of Pvms no 011001, Inj Recombinant Human Tissue-Type Plasminogenactivator (Tpa) Powder

TOT Ref No.: 99861102

Deadline: 07 May 2024

Country: India

Nmcri Drug

TOT Ref No.: 99904743

Deadline: 22 Apr 2024

Country: {{rowDetails.Country_Name}}

TOT Ref No.: {{rowDetails.ID}}

Deadline: {{rowDetails.Bid_Deadline_1}}

Deadline: {{rowDetails.Bid_Deadline_1}}

No data Found!! Please search again

Browse Tenders

Browse Tenders from below Sections

Call Action

Get A Callback Within 24 Hours

Fill form below to get callback from Tender Experts.

Click button to send your details.